AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders
VALENCIA, Calif. and MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ:RCEL, ASX:AVH) (Company), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today announced the results of its 2022 Annual Meeting of Stockholders, which was held virtually on December 12, 2022 (United States) (being December 13, 2022 in Australia).
Related news for (RCEL)
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Appoints New Non-Executive Member to the Board of Directors